Cuproptosis-related gene FDX1 as a prognostic biomarker for kidney renal clear cell carcinoma correlates with immune checkpoints and immune cell infiltration
Background: Kidney renal clear cell carcinoma (KIRC) is not sensitive to radiotherapy and chemotherapy, and only some KIRC patients can benefit from immunotherapy and targeted therapy. Cuproptosis is a new mechanism of cell death, which is closely related to tumor progression, prognosis and immunity...
Main Authors: | Yimin Yao, Haixin Chen, Minjun Lou, Tingting Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-01-01
|
Series: | Frontiers in Genetics |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fgene.2023.1071694/full |
Similar Items
-
Prognostic, Clinicopathological, and Function of Key Cuproptosis Regulator <i>FDX1</i> in Clear Cell Renal Cell Carcinoma
by: Song Zeng, et al.
Published: (2022-09-01) -
Cuproptosis-related gene FDX1 expression correlates with the prognosis and tumor immune microenvironment in clear cell renal cell carcinoma
by: Tao Wang, et al.
Published: (2022-09-01) -
Ferredoxin 1, the key regulator of cuproptosis, was associated with prognosis and immune cell infiltration in clear cell renal cell carcinoma
by: Dian Xia, et al.
Published: (2023-03-01) -
Systematic analysis based on the cuproptosis-related genes identifies ferredoxin 1 as an immune regulator and therapeutic target for glioblastoma
by: Lirui Dai, et al.
Published: (2023-12-01) -
Cuproptosis key gene FDX1 is a prognostic biomarker and associated with immune infiltration in glioma
by: Hanwen Lu, et al.
Published: (2022-11-01)